FOLH1 and neoplasm: Study participation will allow patients to obtain targeted core biopsies of additional PSMA-PET/CT suspicious areas not noticed on MRI, as well as a potential advantage in oncologic therapy by possibly increasing detection of local metastases or local tumor spread.